By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AC Immune SA 

PSE Building B - EPFL

Lausanne    CH-1015  Switzerland
Phone: 41-21-693-9121 Fax: 41-21-693-9120


Company News
AC Immune SA And Essex Bio-Technology Announce Research Collaboration For Neurodegenerative Diseases And Neuroinflammation 5/22/2017 10:30:16 AM
AC Immune SA Reports First Quarter 2017 Financial Results 5/11/2017 11:29:10 AM
AC Immune SA Announces Results Of Annual General Meeting 11/15/2016 8:22:39 AM
Alzheimer's Biotech AC Immune SA Eyes $700 Million IPO Valuation 9/14/2016 6:20:23 AM
Alzheimer's Biotech AC Immune SA Files for $50 Million U.S. IPO 6/1/2016 7:21:18 AM
Biogen (BIIB)'s Partner AC Immune SA Reels In $43.5 Million for Alzheimer's and Neurodegenerative Diseases R&D 5/10/2016 7:39:36 AM
AC Immune SA Announces A Research And Development Collaboration In Neurodegenerative Diseases With Biogen (BIIB) 4/18/2016 9:57:28 AM
AC Immune SA Release: World’s First Clinical Trial For Anti-Abeta Vaccine Targeting Alzheimer’s Disease-Like Characteristics In People With Down Syndrome 1/7/2016 11:14:27 AM
Johnson & Johnson (JNJ) Strikes $509 Million Alzheimer's Deal With AC Immune SA 1/12/2015 6:17:40 AM
AC Immune SA And Piramal Imaging Announce Out-Licensing Agreement For The Development Of Tau Protein Diagnostics In Alzheimer's Disease 5/12/2014 10:01:08 AM